MedPath

EdiGene Inc.

EdiGene Inc. logo
🇨🇳China
Ownership
Holding
Established
2015-05-25
Employees
101
Market Cap
-
Website
https://www.edigene.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus

Phase 1
Not yet recruiting
Conditions
Lupus Erythematosus, Systemic
Interventions
First Posted Date
2024-04-18
Last Posted Date
2024-06-17
Lead Sponsor
EdiGene Inc.
Target Recruit Count
12
Registration Number
NCT06373991
Locations
🇨🇳

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.